- Undercover video released Wednesday by Project Veritas shows Pfizer executive Dr. Jordon Walker—a medical doctor who graduated from Yale and UT Southwestern—claiming that his company was exploring ways to “mutate” coronavirus via “directed evolution.”
- Dr. Walker revealed Pfizer scientists were “optimizing” the virus’ mutation process by putting “the virus in monkeys” and worried about potential outbreaks.
- Pfizer announced back in September 2020 that it was conducting COVID-19-related studies with macaque monkeys.
- Less than a month later, the Delta variant of the virus was discovered in India, where Pfizer has been operating since 1950 (Mumbai).
- The Delta variant is “twice as contagious” as initial COVID variants and more likely to “put infected people in the hospital.”
- Delta was first discovered in Maharashtra, India, the state in which Mumbai is located.
A new video released by Project Veritas on Wednesday showed Pfizer Inc. executive Dr. Jordon Trishton Walker claiming that his company had been exploring ways to “mutate” the coronavirus via “directed evolution.” He revealed that Pfizer scientists had been “optimizing” the virus’ mutation process by putting “the virus in monkeys” and worried about potential outbreaks.
Dr. Walker graduated from Yale and the University of Texas Southwestern medical school, according to Project Veritas founder James O’Keefe.
“We can do these selected structure mutations to make [coronaviruses] more potent,” the Pfizer executive said. “There is research ongoing about that. I don’t know how that is going to work. There better not be any more outbreaks because Jesus Christ.”
Pfizer announced it was conducting COVID-19-related studies with macaque monkeys in a press release published on September 9, 2020. And the first case of Delta, a variant of SARS-CoV-2, was discovered in India—where Pfizer has been operating for over half a century—on October 5, 2020, according to the World Health Organization (WHO), less than a month after Pfizer announced its COVID-related monkey research.
Pfizer has worked in India since 1950, its operations comprising “three manufacturing plants, two R&D centers and six regional centers for commercial operations and global support functions,” according to the company webpage. The pharmaceutical company represents “the fourth largest multinational pharmaceutical company in India.” Its headquarters are located in densely populated Mumbai, India’s largest city, on the country’s west coast.
The Delta variant was first discovered in Maharashtra, India, the state where Mumbai is located.
“B.1.617.2, a variant of Covid-19 is known as the Delta variant. It was first identified in October 2020 in India, and was primarily responsible for the second wave in the country, today accounting for over 80 percent of new Covid-19 cases,” said Dr. NK Arora, co-chair of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), according to The Hindustan Times. “It emerged in Maharashtra and traveled northwards along the western states of the country before entering the central and the eastern states.”
The Delta variant was determined to be “twice as contagious” as initial COVID variants and more likely to “put infected people in the hospital,” an outcome echoing what Pfizer’s Dr. Walker admitted about his company mutating and optimizing coronavirus to be “more potent.” Yale Medicine says Delta was “more than twice as contagious as previous variants” and that “studies have shown it to be more likely than the original virus to put infected people in the hospital.”
“Does this undercover video mean that Pfizer has been using macaque monkeys in directed man-made mutagenic experiments?” asked Dr. Richard Bartlett, a 30-year medical practitioner and former appointee to then-Texas Gov. Rick Perry’s Health Disparities Task Force. “I also think it’s interesting that Pfizer has been in India since 1950 and that the first significant COVID variant, the Delta variant, appeared in India.”
“Dr. Walker has been working on the inside at Pfizer for a long time. Do his statements connect the dots between rapidly appearing mutations and a pharmaceutical company that is not only conducting directed mutations research but also providing the solution of a vaccine?”
Since at least 2019, the U.S. National Institutes of Health (NIH) has invested tens of millions of dollars in COVID-related research involving macaques.